D-0054-2016 Class III Ongoing
FDA drug recall D-0054-2016 was initiated by Hospira Inc. on Sep 29, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing. The recall status is ongoing. Affected quantity: 24,100 Syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 28, 2015
- Initiation Date
- Sep 29, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,100 Syringes
Product Description
Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL), LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-8060-29
Reason for Recall
Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing.
Distribution Pattern
Nationwide
Code Information
Lot 34-531-DK, Exp 10/01/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0054-2016
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026